Esketamine Spray Nasal: A Supervised Treatment Option for Adults With Treatment-Resistant Depression
Esketamine spray nasal treatment is an FDA-approved, prescription therapy used for adults experiencing treatment-resistant depression (TRD). Unlike traditional oral antidepressants, esketamine nasal spray (Spravato®) is administered in a certified clinical setting under medical supervision. Because of its unique mechanism of action, esketamine offers an alternative pathway for adults whose depressive symptoms have not adequately improved […]